June 28, 2017 at 11:30 am PT/2:30 pm ET


Webinar: Alzheimer’s Disease: Clinical and Research Update

Register to watch on demand (1 hour, 4 minutes)

Alzheimer’s disease (AD) cases are expected to rise rapidly in the coming years. By 2050, more than 13.8 million people older than 65 may be living with AD in the United States.1

No proven strategies currently exist for preventing or curing AD. However, with increased momentum in Alzheimer’s research in the last decade, it is crucial for primary care healthcare providers to stay current on the latest advancements in diagnosis, treatment, care and research.

Join Dr. Richard Isaacson of Weill Cornell Medicine/NewYork-Presbyterian Hospital as he provides an overview of AD, including pathology, risk factors, current guidelines on treatment, notable research milestones, ongoing and future research and more.

This webinar is designed for primary care practitioners and all allied health professionals.

1. Hebert, L. E. et al. “Alzheimer Disease In The United States (2010-2050) Estimated Using The 2010 Census”. Neurology 80.19 (2013): 1778-1783. Web.

Reference: https://www.ncbi.nlm.nih.gov/pubmed/28449849

About the speaker:

Richard S. Isaacson, M.D., is Director of the Alzheimer’s Prevention Clinic and Associate Professor of Neurology at Weill Cornell Medicine/NewYork-Presbyterian Hospital. A graduate of the accelerated B.A./M.D. program at the University of Missouri – Kansas City School of Medicine, Dr. Isaacson now specializes in Alzheimer’s disease (AD) risk reduction and treatment, mild cognitive impairment due to AD and pre-clinical AD. His AD research focuses on nutrition and the implementation and longitudinal assessment of dietary interventions for AD management. Dr. Isaacson has a family history of AD, including his Uncle Bob (diagnosed while he was in high school) and his dad’s cousin (diagnosed six years ago) and passionately believes in a comprehensive, multi-modal approach toward both AD treatment and risk reduction.